Rational Design of Nanocarriers for Intracellular Protein Delivery
- PMID: 31496027
- DOI: 10.1002/adma.201902791
Rational Design of Nanocarriers for Intracellular Protein Delivery
Abstract
Protein/antibody therapeutics have exhibited the advantages of high specificity and activity even at an extremely low concentration compared to small molecule drugs. However, they are accompanied by unfavorable physicochemical properties such as fragile tertiary structure, large molecular size, and poor penetration of the membrane, and thus the clinical use of protein drugs is hindered by inefficient delivery of proteins into the host cells. To overcome the challenges associated with protein therapeutics and enhance their biopharmaceutical applications, various protein-loaded nanocarriers with desired functions, such as lipid nanocapsules, polymeric nanoparticles, inorganic nanoparticles, and peptides, are developed. In this review, the different strategies for intracellular delivery of proteins are comprehensively summarized. Their designed routes, mechanisms of action, and potential therapeutics in live cells or in vivo are discussed in detail. Furthermore, the perspective on the new generation of delivery systems toward the emerging area of protein-based therapeutics is presented as well.
Keywords: inorganic nanoparticles; lipids; polymeric nanoparticles; protein delivery.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Tailoring nanocarriers for intracellular protein delivery.Chem Soc Rev. 2011 Jul;40(7):3638-55. doi: 10.1039/c0cs00227e. Epub 2011 May 12. Chem Soc Rev. 2011. PMID: 21566806 Review.
-
Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.J Mater Chem B. 2019 Feb 28;7(8):1209-1225. doi: 10.1039/c8tb02946f. Epub 2019 Jan 18. J Mater Chem B. 2019. PMID: 32255160 Review.
-
Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.Biomater Sci. 2017 Sep 26;5(10):1944-1961. doi: 10.1039/c7bm00425g. Biomater Sci. 2017. PMID: 28776612 Review.
-
Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.Colloids Surf B Biointerfaces. 2014 Nov 1;123:143-9. doi: 10.1016/j.colsurfb.2014.09.009. Epub 2014 Sep 16. Colloids Surf B Biointerfaces. 2014. PMID: 25262409
-
Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.Ther Deliv. 2016;7(4):257-78. doi: 10.4155/tde-2015-0012. Ther Deliv. 2016. PMID: 27010987 Free PMC article. Review.
Cited by
-
Targeted Myoglobin Delivery as a Strategy for Enhancing the Sensitivity of Hypoxic Cancer Cells to Radiation.iScience. 2020 Jun 26;23(6):101158. doi: 10.1016/j.isci.2020.101158. Epub 2020 May 19. iScience. 2020. PMID: 32464594 Free PMC article.
-
A lava-inspired proteolytic enzyme therapy on cancer with a PEG-based hydrogel enhances tumor distribution and penetration of liposomes.J Nanobiotechnology. 2024 May 2;22(1):216. doi: 10.1186/s12951-024-02468-7. J Nanobiotechnology. 2024. PMID: 38698399 Free PMC article.
-
Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats.Nat Commun. 2024 Jan 6;15(1):328. doi: 10.1038/s41467-023-44662-5. Nat Commun. 2024. PMID: 38184609 Free PMC article.
-
A light-activated polymer with excellent serum tolerance for intracellular protein delivery.Chem Sci. 2023 Jan 21;14(8):2046-2053. doi: 10.1039/d2sc05848k. eCollection 2023 Feb 22. Chem Sci. 2023. PMID: 36845943 Free PMC article.
-
Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier.J Control Release. 2021 Nov 10;339:248-258. doi: 10.1016/j.jconrel.2021.09.026. Epub 2021 Sep 24. J Control Release. 2021. PMID: 34563592 Free PMC article.
References
-
- B. Leader, Q. J. Baca, D. E. Golan, Nat. Rev. Drug Discovery 2008, 7, 21.
-
- C. Ng, M. S. H. Guan, C. Koh, X. Ouyang, F. Yu, E. Tan, S. P. O'Neill, X. Zhang, J. Chung, K. Lim, J. Neurosci. 2012, 32, 14311.
-
- L. Hang, J. Thundyil, K. Lim, Ann. N. Y. Acad. Sci. 2015, 1350, 37.
-
- F. Du, Q. Yu, S. Yan, G. Hu, L. Lue, D. G. Walker, L. Wu, S. F. Yan, K. Tieu, S. S. Yan, Brain 2017, 140, 3233.
-
- M. Yu, J. Wu, J. Shi, O. C. Farokhzad, J. Controlled Release 2016, 240, 24.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources